Peloton Therapeutics Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
64
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$2.35B
Peloton Therapeutics General Information
Description
Peloton Therapeutics Inc is a clinical stage biopharmaceutical company focused on translating novel scientific insights into medicines for patients with cancer and other debilitating or life-threatening conditions. It is focused on targeting HIF-2a, a transcription factor which was thought to be intractable using a small molecule. The company's drug candidate, PT2977, has shown clinical proof of concept in patients with advanced or metastatic clear cell renal cell carcinoma.
Contact Information
Website
www.pelotontherapeutics.comCorporate Office
- 2330 Inwood Road
- Suite 226
- Dallas, TX 75235
- United States
Corporate Office
- 2330 Inwood Road
- Suite 226
- Dallas, TX 75235
- United States
Peloton Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Merger/Acquisition | 20-Sep-2019 | $2.35B | Completed | Clinical Trials - Phase 2 | ||
| 8. IPO | 26-Apr-2019 | Cancelled | Clinical Trials - Phase 2 | |||
| 7. Later Stage VC (Series E) | 20-Feb-2019 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series D) | 14-Mar-2017 | Completed | Clinical Trials - Phase 2 | |||
| 5. Grant | 05-Aug-2016 | Completed | Clinical Trials - Phase 2 | |||
| 4. Later Stage VC (Series C) | 05-Nov-2014 | Completed | Clinical Trials - Phase 1 | |||
| 3. Early Stage VC (Series B) | 18-Dec-2013 | Completed | Startup | |||
| 2. Grant | $11M | $18M | Completed | Startup | ||
| 1. Early Stage VC (Series A) | 27-Jul-2011 | $18M | $18M | Completed | Startup |
Peloton Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series E | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B | 10,080,000 | $0.000100 | $0.1 | $1.25 | $1.25 | 1x | $1.25 | 7.68% |
| Series A | 17,100,000 | $0.000100 | $0.08 | $1 | $1 | 1x | $1 | 13.03% |
Peloton Therapeutics Comparisons
Industry
Financing
Details
Peloton Therapeutics Competitors (92)
One of Peloton Therapeutics’s 92 competitors is CEL-SCI, a Corporation company based in Vienna, VA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CEL-SCI | Corporation | Vienna, VA | ||||
| Ampio Pharmaceuticals | Corporation | Englewood, CO | ||||
| AB Science | Formerly Accelerator/Incubator backed | Paris, France | ||||
| Hansa Biopharma | Corporation | Lund, Sweden | ||||
| Crinetics Pharmaceuticals | Formerly VC-backed | San Diego, CA |
Peloton Therapeutics Patents
Peloton Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025184010-A1 | N-biaryl sulfonamides as modulators of the hippo pathway | Pending | 01-Mar-2024 | ||
| EP-4387610-A1 | Tricyclic sultams and sulfamides as antitumor agents | Pending | 12-Oct-2021 | ||
| EP-4387610-A4 | Tricyclic sultams and sulfamides as antitumor agents | Pending | 12-Oct-2021 | ||
| US-20240294548-A1 | Tricyclic sultams and sulfamides as antitumor agents | Pending | 12-Oct-2021 | ||
| WO-2023064058-A1 | Tricyclic sultams and sulfamides as antitumor agents | Inactive | 12-Oct-2021 | C07D513/04 |
Peloton Therapeutics Signals
Peloton Therapeutics FAQs
-
When was Peloton Therapeutics founded?
Peloton Therapeutics was founded in 2011.
-
Where is Peloton Therapeutics headquartered?
Peloton Therapeutics is headquartered in Dallas, TX.
-
What is the size of Peloton Therapeutics?
Peloton Therapeutics has 64 total employees.
-
What industry is Peloton Therapeutics in?
Peloton Therapeutics’s primary industry is Drug Discovery.
-
Is Peloton Therapeutics a private or public company?
Peloton Therapeutics is a Private company.
-
What is the current valuation of Peloton Therapeutics?
The current valuation of Peloton Therapeutics is .
-
What is Peloton Therapeutics’s current revenue?
The current revenue for Peloton Therapeutics is .
-
How much funding has Peloton Therapeutics raised over time?
Peloton Therapeutics has raised $287M.
-
Who are Peloton Therapeutics’s competitors?
CEL-SCI, Ampio Pharmaceuticals, AB Science, Hansa Biopharma, and Crinetics Pharmaceuticals are some of the 92 competitors of Peloton Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process